Literature DB >> 17885735

Topical henna for capecitabine induced hand-foot syndrome.

Idris Yucel1, Gonullu Guzin.   

Abstract

Capecitabine is a chemotherapeutic drug for use in cancers. Hand-foot syndrome (HFS) is side effect of capecitabine which can lead the cessation of the therapy or dose reduction. Henna (Lawsonia inermis) is a traditionally used plant of Middle-East that is applied on hands and feet. Some of cancer patients in capecitabine treatment who developed HFS, we recommended to apply henna. In these patients, six patients were grade 3 HFS and four were grade 2 HFS. Complete response (CR) were seen in four of grade 3 HFS and all of grade 2; two grade 3 HFS improved to grade 1. So far, in the chemotherapy, there was no need of dose reduction and also no side effect of henna seen. Clinical improvement in these patients may relate to anti-inflammatory, antipyretic and analgesic effects of henna. Prospective studies are needed to show this therapeutic effect of henna.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885735     DOI: 10.1007/s10637-007-9082-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  14 in total

1.  Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.

Authors:  A M Lopez; L Wallace; R T Dorr; M Koff; E M Hersh; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

2.  Antioxidant and immunomodulatory constituents of henna leaves.

Authors:  Botros R Mikhaeil; Farid A Badria; Galal T Maatooq; Mohamed M A Amer
Journal:  Z Naturforsch C J Biosci       Date:  2004 Jul-Aug

3.  Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Authors:  C J Fabian; R Molina; M Slavik; S Dahlberg; S Giri; R Stephens
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

4.  Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats.

Authors:  B H Ali; A K Bashir; M O Tanira
Journal:  Pharmacology       Date:  1995-12       Impact factor: 2.547

5.  Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Authors:  J L Blum; S E Jones; A U Buzdar; P M LoRusso; I Kuter; C Vogel; B Osterwalder; H U Burger; C S Brown; T Griffin
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

Review 6.  Current Canadian experience with capecitabine: partnering with patients to optimize therapy.

Authors:  Bonnie-Mae Gerbrecht
Journal:  Cancer Nurs       Date:  2003-04       Impact factor: 2.592

7.  Henna (Lawsonia inermis Linn.) inducing haemolysis among G6PD-deficient newborns. A new clinical observation.

Authors:  H H Kandil; M M al-Ghanem; M A Sarwat; F S al-Thallab
Journal:  Ann Trop Paediatr       Date:  1996-12

8.  Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy.

Authors:  K B Gordon; A Tajuddin; J Guitart; T M Kuzel; L R Eramo; J VonRoenn
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

Review 9.  Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda).

Authors:  Hilde Marsé; Eric Van Cutsem; Axel Grothey; Sonia Valverde
Journal:  Eur J Oncol Nurs       Date:  2004       Impact factor: 2.398

10.  Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

Authors:  A Comandone; S Bretti; G La Grotta; S Manzoni; G Bonardi; R Berardo; C Bumma
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

View more
  12 in total

Review 1.  Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems.

Authors:  Javad Sharifi-Rad; Antoni Sureda; Gian Carlo Tenore; Maria Daglia; Mehdi Sharifi-Rad; Marco Valussi; Rosa Tundis; Marzieh Sharifi-Rad; Monica R Loizzo; Adedayo Oluwaseun Ademiluyi; Razieh Sharifi-Rad; Seyed Abdulmajid Ayatollahi; Marcello Iriti
Journal:  Molecules       Date:  2017-01-01       Impact factor: 4.411

Review 2.  Integrative oncology research in the Middle East: weaving traditional and complementary medicine in supportive care.

Authors:  Eran Ben-Arye; Mohammed Saleem Ali-Shtayeh; Mati Nejmi; Elad Schiff; Esmat Hassan; Kamer Mutafoglu; Fatma U Afifi; Rana Majed Jamous; Efraim Lev; Michael Silbermman
Journal:  Support Care Cancer       Date:  2011-03-01       Impact factor: 3.603

3.  Qualitative content analysis of complementary topical therapies used to manage diabetic foot in Jordan.

Authors:  Ma'en Zaid Abu-Qamar; Anne Wilson
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

4.  Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.

Authors:  Sepideh Elyasi; Sara Rasta; Ali Taghizadeh-Kermani; Sare Hosseini
Journal:  Daru       Date:  2022-03-23       Impact factor: 4.088

Review 5.  Plants used to treat skin diseases.

Authors:  Nahida Tabassum; Mariya Hamdani
Journal:  Pharmacogn Rev       Date:  2014-01

6.  The Effect of Henna (Lawsonia Inermis) on Preventing the Development of Pressure Ulcer Grade One in Intensive Care Unit Patients.

Authors:  Zahra Rafiei; Mohammad Mazaheri; Maryam Eghbali-Babadi; Ahmadreza Yazdannik
Journal:  Int J Prev Med       Date:  2019-02-15

Review 7.  Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.

Authors:  Jade Cury-Martins; Adriana Pessoa Mendes Eris; Cristina Martinez Zugaib Abdalla; Giselle de Barros Silva; Veronica Paula Torel de Moura; Jose Antonio Sanches
Journal:  An Bras Dermatol       Date:  2020-02-15       Impact factor: 1.896

8.  Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial.

Authors:  Mansour Ansari; Dehsara Farzin; Ahmad Mosalaei; Shapour Omidvari; Niloofar Ahmadloo; Mohammad Mohammadianpanah
Journal:  Iran J Med Sci       Date:  2013-12

9.  Henna ( Lawsonia inermis) as an Inexpensive Method to Prevent Decubitus Ulcers in Critical Care Units: A Randomized Clinical Trial.

Authors:  Davood Hekmatpou; Fatemeh Ahmadian; Maryam Eghbali; Shadi Farsaei
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec

10.  Comparing the Effect of Henna Oil and Olive Oil on Pressure Ulcer Grade One in Intensive Care Units Patients.

Authors:  Elahe Poursadra; Motahare Anvari-Tafti; Asieh Dehghani; Maryam Eghbali-Babadi; Zahra Rafiei
Journal:  Adv Biomed Res       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.